Cars.com
CARS
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
New Fortress Energy
NFE
Teradata Corp
TDC
Halozyme Therapeutics
HALO
US Stock MarketDetailed Quotes
BFRI Biofrontera
- 1.0200
- -0.0300-2.86%
Trading Jan 15 15:34 ET
7.90MMarket Cap0.88P/E (TTM)
1.0500High0.9701Low214.41KVolume1.0500Open1.0500Pre Close216.90KTurnover3.81%Turnover RatioLossP/E (Static)7.75MShares2.430252wk High1.43P/B5.74MFloat Cap0.610052wk Low--Dividend TTM5.63MShs Float292.6000Historical High--Div YieldTTM7.61%Amplitude0.6100Historical Low1.0110Avg Price1Lot Size
Biofrontera Key Stats
EPS
According to the latest financial report of Biofrontera, the latest earnings per share (TTM) for the company is -0.98. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Biofrontera's free cash flow? The latest report shows it as -1.21M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Biofrontera shows that the company's current ratio is 1.53, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Biofrontera, the quick ratio is 0.70, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Biofrontera? The latest ROE figure is -68.96%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Biofrontera, the total asset return on investment (ROA) is -28.28%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Biofrontera's latest financial report to see how their gross margin is doing - currently at 45.88%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Biofrontera, the net profit margin is -62.91%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...